Secondary prevention in coronary heart disease. Cost effectiveness of treatment must be borne in mind.
Ferner
R E
RE
D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D019821:Simvastatin / Q000627:therapeutic use
D000960:Hypolipidemic Agents; D019821:Simvastatin; D001241:Aspirin